February 02, 2026 a 01:00 pm
RMD: Fundamental Ratio Analysis - ResMed Inc.
ResMed Inc., a prominent player in the healthcare sector, is known for its robust presence in the medical devices and software applications market. Its performance is promising with solid financials and a positive market outlook. However, potential risks from market dynamics and regulatory changes remain.
Fundamental Rating
ResMed Inc. demonstrates a strong fundamental position with a solid overall score and specific strengths in key financial metrics.
| Category | Score | Bar |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 3 | |
| Price To Earnings | 2 | |
| Price To Book | 2 |
Historical Rating
Reviewing past performance scores gives insight into the stability and trends in the company's financial health.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-02 | 4 | 4 | 5 | 5 | 3 | 2 | 2 |
| 2026-01-30 | 4 | 4 | 5 | 5 | 3 | 2 | 2 |
Analysts' Price Targets
The price target analysis suggests a positive outlook, with room for stock appreciation based on projected estimates.
| High | Low | Median | Consensus |
|---|---|---|---|
| $345 | $265 | $291.5 | $295.88 |
Analysts' Sentiment
The analyst sentiment reflects a general buy consensus, indicating confidence in the stock's potential.
| Rating | Count | Bar |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 14 | |
| Sell | 5 | |
| Strong Sell | 0 |
Conclusion
ResMed Inc. stands out in the healthcare market with its strong financial performance and innovative product lineup. Investors should be aware of potential headwinds, such as market volatility and regulatory changes, but the company's solid fundamentals and positive analyst ratings indicate promising growth potential. Careful monitoring of industry trends and competitive dynamics is advised. Overall, ResMed's stock presents an attractive opportunity for growth-focused investors.